___

• Garten RJ, Davis CT, Russell CA et al. Antigenic and genetic charac- teristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009; 325: 197.
• Smorodintseva ЕА, Sominina АА, Каrpova LS. Comparative data on the development of influenza pandemic in Russia and in the other Euro- pean countries (in Russian). Materials of the II Annual all-Russian Con- gress on Infectious Diseases. 2010 March 29-31; Moscow, 2010. p. 295.
• L’vov DK, Burtseva EI, Prilipov AG et al. Isolation on 24.05.2009 and deposition in the State Virus Collection of the first strain А/Mos- cow/01/2009 (H1N1)swl, similar to the swine virus A(H1N1) from the first patient diagnosed in Moscow 21.05.2009 (in Russian). Problems of Virology. 2009; 5: 10-14.
• Sominina АА, Burtseva EI, Коnovalova NI et al. Isolation of influ- enza viruses in cell cultures and in chicken embryos and their identifica- tion. Methods guidance (in Russian). Moscow. 2006.
• Clavijo A, Tresnan DB, Jolie R, Zhou E-M. Comparison of embryo- nated chicken eggs with MDCK cell culture for the isolation of swine influenza virus. Can. J. Vet. Res. 2002; 66: 117-121.
• Li IWS, Chan KH, To KWK et al. Differential susceptibility of dif- ferent cell lines to swine-origin influenza A H1N1, seasonal human in- fluenza A H1N1, and avian influenza A H5N1 viruses . J. Clin. Virol. ; 46: 325-330. Grudinin MP, Komissarov AV, Eropkin MU et al. Molecular genetic characterization of the strains of pandemic influenza A(H1N1)v isolat- ed on the territory of Russian Federation in 2009 (in Russian). Materi- als of the II Annual all-Russian Congress on Infectious Diseases. 2010 March 29-31; Moscow, 2010. p. 82-83.
• Xu X, Rocha EP, Regenery HL et al. Genetic and antigenic analyses of influenza A (H1N1) viruses, 1986-1991. Virus Res. 1993; 28:37–55
• Nicholls JM, Bourne AJ, Chen H et al. Sialic acid receptor detection in the human respiratory tract: evidence for widespread distribution of potential binding sites for human and avian influenza viruses. Respir. Res. 2007; 8: 73.
• European Center of Disease Control and Prevention (ECDC). 2009 pandemic influenza A(H1N1) virus mutations reported to be associated with severe Disease (23 Dec 2009). Available from: http://ecdc.europa. eu/en/activities/sciadvice
• Responsible person:Dr. Mihkail EROPKIN Research Institute of Influenza of The Russian Academy of Medical Science /17 Popova Str. 197376 St.Petersburg, Russia email:eropkin@influenza.spb.ru
• Paratiroid Patolojilerini Görüntülemede Sintigrafik Yöntemler Ayşe Esra ARSLAN, İrfan PEKSOY, Pelin ARICAN Ankara Numune Eğitim ve Araştırma Hastanesi, Nükleer Tıp Kliniği, Ankara - TÜRKİYE Geliş Tarihi: 11.01.2011 Kabul Tarihi: 23.02.2011
• Se-75: 1960’larda paratiroid patolojilerini görüntülemede ilk kullanılan RF’tir. Ancak görüntü kalitesinin kötü olma- sı, hasta dozimetrisi ve daha uygun RF’ler geliştirilmesin- den dolayı kısa sürede kullanımdan kalkmıştır.
• Niederle B, Roka R, Woloszczuk W. et al: Successful parathyroidec- tomy in primary hyperparathyroidism: A clinical follow up study of 212 consecutive patients. Surgery 1987; 102:903-909.
• Mariani G, Gulec SA, Rubello D, et al: Preoperative localization and radioguided parathyroid surgery. J Nucl Med 2003;44:1443-1458.
• Lumachi F, Ermani M, Basso S, et al: Localization of parathyroid tu- mours in the minimally invasive era: which technique should be cho- sen? Population based analysis of 253 patients undergoing parathyroi- dectomy and factors affecting parathyroid gland detection. Endocr Re- lat Cancer 2001; 8:63-69.
• Krusback AJ, Wilson SD, Lawson TL, et al: Prospective comparison of radionuclide, computed tomographic, sonographic, and magnetic re- sonance localization of parathyroid tumors. Surgery 1989;106:639-646.
• Akbaba G, Berker D, Aydın Y ve ark. Comparison of Preoperati- ve Examinations in Patients with Primary Hyparparathyroidism: US, MIBI, SPECT and MRI. ENDO 2010 Abstract Book, Endocrine Revi- ews, Supplement 1, June 2010; 31(3): S1119.
• Takeda M, Katayama Y, Kimura M, et al. Localizing methods of pri- mary hiperparathyroidism and those results. Nippon Hinyokika Gakkai Zasshi. 1990 May;81(5):707-12.
• Hindié E, Ugur O, Fuster D et al. 2009 EANM parathyroid guideli- ne; Eur J Nucl Med Mol İmaging 2009; 36:1201-1216.
• Demir M, Nükleer Tıp Fiziği ve Klinik Uygulamaları, İstanbul, Lorberboym M, Minski I, Macadziob S, et al: Incremental diagnos- tic value of preoperative 99mTc-MIBI SPECT in patients with a parath- yroid adenoma. J Nucl Med 2003;44:904-908.
• Sharma J, Mazzaglia P, Milas M et al; Radionuclide imaging for hyperparathyroidism (HPT): which is the best technetium-99m sestami- bi modality? Surgery. 2006 Dec; 140(6):856-63 discussion 863-5.
• DiGuilo W, Beierwalters WH: Parathyroid scanning with seleni- um-75 labeled methionine. J Nucl Med 1964;5:417.
• Ferlin G, Borsato N, Camerani M, et al: New perspectives in loca- lizing enlarged parathyroids by technetium-thallium subtraction scan. J Nucl Med 1983;24:438-441.
• Coakley AJ, Kettle AG, Wells CP, et al: 99mTc-sestamibi—a new agent for parathyroid imaging. Nucl Med Commun 1989;10:791-794.
• Vallejos V, Martin-Comin J, Gonzalez MT, et al: The usefulness ofTc-99m tetrofosmin scintigraphy in the diagnosis and localization of hyperfunctioning parathyroid glands. Clin Nucl Med 1999; 24:959-964.
• Palestro CJ, Tomas MB, Tronco GG; Radionuclide imaging of the parathyroid glands; Semin Nucl Med. 2005 Oct;35(4):266-276.
• Basso LV, Keeling C, Goris ML: Parathyroid imaging: use of dual isotope scintigraphy for the localization of adenoma before surgery. Clin Nucl Med 1992;17:380-383.
• Hindié E, Mellière D, Jeanguillaume C, Perlemuter L, Chéhadé F, Galle P. Parathyroid imaging using simultaneous double-window recor- ding of technetium-99m-sestamibi and iodine-123. J Nucl Med. 1998 Jun;39(6):1100-5.
• Serra A, Bolasco P, Satta L, Nicolosi A, Uccheddu A, Piga M. Role of SPECT/CT in the preoperative assessment of hyperparathyroid pati- ents. Radiol Med. 2006 Oct;111(7):999-1008.
• Lavely WC, Goetze S, Friedman KP et al. Comparison of SPECT/ CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc- sestamibi parathyroid scintigraphy. J Nucl Med.2007 Jul;48(7):1084-9.
• Gayed IW, Kim EE, Broussard WF, et al: The value of Tc-99m- sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia. J Nucl Med 2005;46:248-252.
• Krausz Y, Bettman L, Guralnik L, et al: Tc-99m MIBI SPECT/CT in primary hiperparathyroidism. World J Surg 2006;30: 76-83.
• Garvie NW: Imaging the parathyroids, in Peters AM (ed): Nucle- ar Medicine in Radiologic Diagnosis. London, Martin Dunitz, 2003, pp 681-694
• Sun SS, Shiau YC, Lin CC, et al: Correlation between P-glycoprotein(P-gp) expression in parathyroid and Tc-99m MIBI pa- rathyroid image findings. Nucl Med Biol 2001;28:929-933.
• Hetrakul N, Civelek AC, Stagg CA, et al: In-vitro accumulation of technetium 99m sestamibi in human parathyroid mitochondria. Surgery ;130:1011-1018.
• Melloul M, Paz A, Koren R, et al: 99m Tc-MIBI scintigraphy of parathyroid adenomas and its relation to tumour size and oxyphil cell abundance. Eur J Nucl Med 2001;28:209-213.
• Bhatnagar A, Vezza PR, Bryan JA, et al: Technetium-99m-sestamibi parathyroid scintigraphy: Effect of P-glycoprotein, histology and tumor size on detectability. J Nucl Med 1998;39:1617-1620.
• Heller KS, Attie JN, Dubner S: Parathyroid localization: inability to predict multiple gland involvement. Am J Surg 1993;166:357-359.
• Katz SC, Wang GJ, Kramer EL et al: Limitations of technetium 99m sestamibi scintigraphic localization for primary hyperparathyroidism associated with multiglandular disease. Am Surg 2003;69:170-175.
• Sorumlu Yazar: Dr. İrfan PEKSOY Ankara Numune Eğitim ve Araştırma Hastanesi, Nükleer Tıp Kliniği, Sıhhiye-ANKARA Tel:508 48 78 E.mail: irfanpeksoy67@yahoo.com Food and Drug Administratin (FDA). Update on Bisphenol A for Use in Food Contact Applications U.S. Food and Drug Administration Janu- ary 2010. Erişim Tarihi: 04/10/2010: http:// www. fda.gov.
• World Health Organization (WHO). Bisphenol A (BPA)-Current state of knowledge and future actions by WHO and FAO. International Food Safety Authorities Network (INFOSAN). Erişim Tarihi: 04/10/2010: http:// www.who.int.
• Environment California. Bisphenol A Overwiew. Erişim Tarihi: /09/2010:http://www.environmentcalifornia.org/environmental, he- alth/stop-toxic-toys/bisphenol.
• Fung EYK, Ewoldsen NO, Germain HA at al. Pharmacokinetics of Bisphenol A Released From a Dental Sealant. J Am Dent Assoc, 2000; : 51-58
• Magdelena PA, Morimoto S, Ripoll C, Fuentes E and Nadal A. The Estrogenic Effect of Bisphenol A Disrupts Pancreatic β-Cell Function In Vivo and Induces Insulin Resistance. Environ Health Perspect, 2006; (1): 106-112
• Food and Agriculture Organization (FAO). Joint FAO/WHO Expert meeting to review toxicological and health aspects of Bisfenol A. Cana- da, October 2010. Erişim Tarihi: 04/10/2010: http:// www.fao.org.
• Cagen SZ, Waechter JM, Dimond SS at al. Normal Reproduktive Or- gan Development in CF-1 Mice following Prenatal Exposure to Bisp- henol A. Toxicological Sciences, 1999; 50: 30-44
• Al-Hiyasat AS, Darmani H and Elbetieha AM. Effects of Bisphenol A on Adult Male Mouse Fertility. Eur J Oral Sci. 2002; 110 (2): 163-167
• Rubin BS, Murray MK, Damassa DA, King JC and Soto AM. Perina- tal Exposure to Low Doses of Bisphenol A Affects Body Weight, Pat- terns of Estrous Cyclicity, and Plasma LH Levels. Environ Health Pers- pect, 2001; 109 (7): 675-680
• Bisphenol A: Information Sheet. Erişim Tarihi: 04/10/2010: http:// www.bisphenol-a.org/pdf/pharmacokineticsOctober2002.pdf.
• Tarım ve Köyişleri Bakanlığı. Gıda Maddeleri ile Temasta Bu- lunan Plastik Madde ve Malzemeler Tebliği (Tebliğ Nu.: 2005/31).
• /07/2005 tarihli ve 25865 sayılı Resmî Gazete.
• Sorumlu Yazar: Dr. Ramazan UZUN Refik Saydam Hıfzıssıhha Merkezi Başkanlığı Zehir Araştırmaları Müdürlüğü, ANKARA Tel:458 24 60 E.mail:ramazan.uzun@rshm.gov.tr; ramazanuzun@yahoo.com Vaka Sunumu Genç Hastada Dev Üreter Taşı: Olgu Sunumu Namık Kemal ALTINBAŞ Sivas Asker Hastanesi Radyoloji Bölümü, Sivas- TÜRKİYE Sabnis RB, Deasi RM, Bradoo AM, Punekar SV, Bapat SD. Giant ureteral stone. J Urol 1995; 148:861-863.
• Pereira AJG, Catalina AJ, Gallego SJA, Gurtubay A. Multiple giant ureteral lithiazis. Arch Esp Urol 1996; 49:984-986.
• Drach GW. Transuretral ureteral Stone manipulation. Urol Clin North Am 1983; 10:709-712.
• Sutor DJ and Wooley SE. Some data on urinary Stones which were passed. Brit. J. Urol 1975; 47:131-134.
• İsen K, Küpeli B, Deniz N, Kordan Y. Bozkırlı İ: Bir dev üreter taşı olgusu. Türk Üroloji Dergisi 1999; 25:221-224.
• Kılıç İ, Gedik A, Akın D. Dev üreter taşı: olgu sunumu. Dicle Tıp Dergisi 2009; 36:47-49.
• Golomb J, Korczak D, Lindner A. Giant obstructing calculus in the distal ureter secondary to obstruction by a ureterocele. Urol Radiol ;168-170. Hemal AK, Sharma DK, Sood R, Wadhwa SN. Giant staghorn urete- ral calculus. Urol Int 1995; 177-178.
• Segura JW, Preminger GM, Assimos DG et al. Nephrolithiasis clini- cal guidelines panel summary report on the management of ureteral cal- culi. J Urol 1997; 158:1915-1921.
• Sorumlu Yazar: Uz. Dr Namık Kemal ALTINBAŞ Sivas Askeri Hastanesi Radyoloji Bölümü, SİVAS- TÜRKİYE Gsm: 0532 702 91 67
• E-mail: namikaltin@gmail.com Namık Kemal ALTINBAŞ Vaka Sunumu A rare case of pedunculated nasal glioma associated with cleft palate and review of literature Murat ANLAR, Tuba Dilay KÖKENEK-ÜNAL, Aynur ALBAYRAK, Murat ALPER II. Pathology Department, Diskapi Yildirim Beyazit Research and Training Hospital, Ankara - TÜRKİYE Shah J, Patkar D, Patankar T, Krishnan A, Prasad S, Limdi J. Pedun- culated nasal glioma: MRI features and review of the literature. J Post- grad Med 1999;45:15-7.
• Verney Y, Zanolla G, Teixeira R, Oliveira LC. Midline nasal mass in infancy: a nasal glioma case report. Eur J Pediatr Surg 2001;11:324-7.
• Wischniewski E, Klaber HG, Oppermann J, Guntschera J, Eichhorn T, Erler T. [Nasal glioma as a rare cause of obstructed nasal breathing in a newborn infant]. Klin Padiatr 2001;213:139-41.
• Uemura T, Yoshikawa A, Onizuka T, Hayashi T. Heterotopic nasop- haryngeal brain tissue associated with cleft palate. Cleft Palate Cranio- fac J 1999;36:248-51.
• Riffaud L, Ndikumana R, Azzis O, Cadre B. Glial heterotopia of the face. J Pediatr Surg 2008;43:e1-e3.
• Chang KC, Leu YS. Nasal glioma: a case report. Ear Nose Throat J ;80:410-1. Wojdas A, Kosek J, Patera J, Jurkiewicz D. [The rare case of nasal glioma]. Otolaryngol Pol 2005;59:617-21.
• Talwar OP, Pradhan S, Swami R. Nasal glioma: a case report. Kath- mandu Univ Med J (KUMJ.) 2007;5:114-5.
• Chau HN, Hopkins C, McGilligan A. A rare case of nasal glioma in the sphenoid sinus of an adult presenting with meningoencephalitis. Eur Arch Otorhinolaryngo l. 2005;262:592-4.
• Penner CR, Thompson L. Nasal glial heterotopia: a clinicopatholo- gic and immunophenotypic analysis of 10 cases with a review of the li- terature. Ann Diagn Pathol 2003;7:354-9.
• Chhatwal HK, Barr KL, Bhattacharyya I, Seagle BM, Vincek V. A newborn born with a large rubbery mass on the left-hand side of the nose. Nasal glial heterotopia (nasal glioma). Pediatr Dermato . ;25:557-8. Ma KH, Cheung KL. Nasal glioma. Hong.Kong.Med.J. 2006;12:477-9.
• Martinez-Lage JF, Garcia-Contreras JD, Ferri-Niguez B, Sola J. Na- sal cerebral heterotopia: nasal atretic cephalocele. Neurocirugia (Astur.) ;13:385-8. Yashar SS, Newbury RO, Cunningham BB. Congenital midline na- sal mass in a toddler. Pediatr Dermatol 2000;17:62-4.
• Oddone M, Granata C, Dalmonte P, Biscaldi E, Rossi U, Toma P. Nasal glioma in an infant. Pediatr Radiol 2002;32:104-5.
• Husein OF, Collins M, Kang DR. Neuroglial heterotopia causing neonatal airway obstruction: presentation, management, and literature review. Eur J Pediatr 2008;167:1351-5.
• Eliasson H, Broman T, Forsman M, Bäck E (2006) Tularemia: Cur- rent epidemiology and disease management. Infect Dis Clin N Am 20: –311
• Perez-Castrillon JL, Bachiller-Luque P, Martin-Luquero M, Mena- Martin FJ, Herreros V (2001) Tularemia epidemic in northwestern Spa- in: clinical description and therapeutic responses. Clin Infect Dis 33: –576
• Wills PI, Gedosh EA, Nichols DR (1982) Head and neck manifestati- ons of tularaemia. Laryngoscope 92: 770–773
• Dlugaiczyk Julia, Harrer Thomas, Zwerina Jochen (2009) Orophary- ngeal tularemia – a differential diagnosis of tonsillopharyngitis and cer- vical lymphadenitis. Wien Klin Wochenschr 122: 110–114
• Rosenberg TL, Brown JJ, Jefferson GD (2010) Evaluating the adult patient with a neck mass. Medical Clinics of North America 94:Issue 5
• Cummings CW, Flint PW, Harker LA, et al: Differential diagnosis of neck masses. Otolaryngology-head and nek surgery, 4th edition Elsevi- er MosbyPhiledelphia2005: 2540-2553
• Olgu sunumlarının giriş ve tartışma kısımları kısa-öz olmalı, kaynak sayısı 15 den az olmalıdır. Kısa raporlara özet yazılmamalı, en fazla 5 adet anahtar kelime, 10 kaynak, 1500 kelime, 2 tablo ve/veya şekil olma- lı ve yazının hemen sonunda sırasıyla yazar isimleri, ünvanları ve yazışma adresleri bulunmalıdır.
• Editöre mektup, dergide daha önce yayımlanmış yazılara bilimsel eleştiri yapmak, katkı sağlamak ya da orjinal bir ça- lışma olarak sunulmamış veya sunulamayacak bilgilerin paylaşılması amacıyla hazırlanmış en fazla 1000 kelimeden olu- şan, kısa-öz ve 6 dan az sayıda kaynağı olmalı özet içermemelidir.